Search
Waning immunity after acellular pertussis (aP) vaccines shown in pertussis outbreaks highlights the need for more effective aP vaccines.
Vancomycin is used to treat serious gram-positive infections in children; however, effective dosing information for those aged 3 months to 18 years is limited. We aimed to determine an optimized dosing strategy for this age group.
Intramuscular (IM) injection of benzathine benzylpenicillin G (BPG) forms the cornerstone of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) secondary prophylaxis. BPG is available as either a low-cost powdered formulation or a costlier pre-filled suspension. Most of the global RHD burden lies in low- and middle-income countries, which rely on the powdered formulation.
Three emerging research projects advancing the Wesfarmers Centre of Vaccines & Infectious Diseases' (WCVID) flagship research priorities have this week received a major funding boost through the latest WCVID Catalyst Grants.
Congratulations to Alec Truswell, Tamara Veselinović, Anastasia Phillips, and Wenna Lee for being awarded Seed Funding through the Wesfarmers Centre of Vaccines & Infectious Diseases, each valued at up to $25,000, and to Sonia McAlister, the recipient of the 2026 Riley Hughes Memorial Award in Pertussis Research.
Innovative research aiming to prevent the spread of Strep A using ‘friendly’ bacteria in the throat has received a $1.5 million boost in the latest round of National Health and Medical Research Council grants.
Free Family-Friendly Science Fun During National Science Week 2025. Get ready for an awesome adventure into the world of Science, Technology, Engineering and Mathematics!
We honour the memory of Emeritus Professor Michael Alpers, a colleague and friend to many at The Kids Research Institute Australia, who passed away on December 3, 2024.
Vital research promoting sun smart choices and skin cancer prevention for young Aboriginal people is now underway at The Kids Research Institute Australia thanks to a $100,000 Perpetual 2024 IMPACT Philanthropy grant.
A team led by Dr Joseph Kado from the Wesfarmers Centre of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, and The University of Western Australia (UWA) has been awarded $5 million by the Federal Government in a major push to prevent rheumatic heart disease across the Pacific.